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INTRODUCTION 
Knowledge about periodontal disease has increase in the 
last years, and it has been found that its pathogenesis is 
very complex, and the presence of virulent 
microorganism is not the only cause of this disorder.
[1]
 
 
It is well established that periodontal disease is 
predominantly a bacterial infection involving the dental 
biofilm or dental plaque. Several studies have identified 
the main pathogens of the subgingival microbiome and 
found that the biofilm that causes this disease is site-
specific, a complex polymicrobial community, resistant 
to the host defense mechanisms and to antimicrobial 
agents. 
 
However, today, it is accepted that the susceptibility to 
periodontal disease varies greatly between individuals 
who have the same pathogenic microflora.
[2]
 Years ago, 
researchers believed that all individuals were equally 
susceptible for periodontal disease
[3]
, but with the 
development of new methodology such as being able to 
asses depth pocket and clinical attachment loss, several 
epidemiological studies found differences in 
susceptibility among different individuals.
[4]
 It was found 
that some individuals throughout their life presented this 
disease and many others did not, pointing to the 
possibility of the existence of other risk factors playing 
an important role in development of periodontitis.
[5] 
 
In the last decades, the believed concept concerning risk 
factors involved in the initiation and progression of 
periodontal disease has changed drastically. It was first 
accepted that the periodontal disease was directly 
triggered by microbial agents. Later, it was identified the 
importance of the immune system and the inflammatory 
response of the host to bacterial infection responsible for 
periodontitis. Nowadays, it is believed that this condition 
is a multifactorial disease where genetic and 
environmental factors are involved.
[6] 
 
The susceptibility to periodontitis and other 
inflammatory diseases seems to change according with 
the interaction of genetic and environmental factors 
during life. Some risk factors can be modified, such as 
depression, psychological stress, obesity, smoke and 
alcohol. These factors increase the inflammatory 
response and modify gene expression through a variety 
of biological mechanisms such as epigenetic 
modifications and gene - environment interaction. 
Greater knowledge concerning genetic and 
environmental risk factors can help the development of 
new therapeutic strategies for these patients, decreasing 
the risk of tooth- loss
[7]
, that would lead to poor 
masticatory function and consequent poorer nutritional 
status, low self-steam and life quality and negative 
general health impacts.
[8,9]
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ABSTRACT  
The goal of this work was to make a search on the genetic and environmental factors involved in the development 
of periodontal disease, in order to have a better understanding and therefore be able to give a better treatment to 
our patients. One of the most common immune/inflammatory disease of infectious origin is the periodontitis. This 
disease can have a negative impact in health and life quality, since patients can lose their teeth. Chronic and 
aggressive periodontal diseases are complex diseases with multifactorial etiology, that result in the destruction of 
the supporting structures of teeth. The immune system of the host plays an important role in this process. As 
environmental risk factors are smoking habits, nutrients and food diet, obesity and involved metabolic syndromes, 
stress and depression. 
Concerning genetic risk factors, several studies show the existence of familial aggregation and polymorphisms of 
diverse genes as well as epigenetic changes have been associated with increased susceptibility to periodontitis. 
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1. Periodontitis etiology and pathogenesis  
The major etiological factor triggering gingival 
inflammation and progression of the inflammatory 
process is bacterial biofilm. The biofilm is complex and 
seems to have many ecological advantages, such as 
environmental protection, nutrients, metabolic 
cooperation and the acquisition of new genetic 
traits.
[10,11]
 In 1994, Socransky and Haffajee identified 
some of the most important microorganisms associated 
with the periodontal disease such as: Porphyromonas 
gingivalis, Tannerella forsythia, Treponema denticola, 
Campylobacter rectus, Micromonas micros, 
Streptococcus intermedius, Eubacterium nodatum, 
Aggregatibacter (formerly Actinobacillus) 
actinomycetemcomitans and Prevotella intermedia. This 
study also found that some bacteria present in tooth 
plaque are more pathogenic than others.
[12] 
 
Moreover, some studies show that viruses can affect the 
hemostasis of the microbial community leading to 
changes in microbial composition.
[13]
 Phages appear to 
play a crucial role in the evolution, diversity and 
abundance of bacteria in ecosystems
[14,15]
, and seem to be 
strongly implicated in the pathogenesis of the periodontal 
disease (specially herpes virus and cytomegalovirus).
[16] 
 
However, periodontal disease is much more complex 
than biofilm (bacteria or viruses), since genetic risk 
factors interfere with the host immune and inflammatory 
response, which can lead to subgingival alterations, 
favoring the proliferation of periodontal pathogens.
[17] 
 
The immune defense system responds to behavioral, 
biological and environmental factors, such as obesity and 
smoking. Work of Cekici et al.
 [18]
 concluded that chronic 
inflammation occurs due to dysregulation of the 
inflammatory and immune process that leads to host 
mediated connective tissue damage and alveolar bone 
loss.
[18]
 
 
2. Aggressive and chronic periodontitis 
Classification of periodontal diseases has suffered many 
changes throughout the years, and the last classification, 
used for many years, dates from 1999 where 
periodontitis was reclassified as chronic, aggressive 
(localized and generalized), necrotizing and as a 
manifestation of systemic disease.
[19] 
 
A lot of studies have emerged since that classification 
and in 2017 a new classification of periodontitis was 
stablished. From that date, three forms of periodontitis 
can be identified: necrotizing periodontitis, periodontitis 
as a manifestation of systemic disease, and the forms of 
the disease previously recognized as “chronic” or 
“aggressive”, now grouped under a single category, 
“periodontitis”.[19] 
 
Since this is a recent classification and most studies used 
in this review were published before and have still used 
previous classification, this work refers to this disease 
with its old classification. 
 
2.1. Chronic periodontitis  
Chronic periodontitis is a set of inflammatory conditions 
that affect tissues surrounding teeth. It is a plaque-
induced disease, where the immune host response plays 
an important role. Some authors claim that it is initiated 
by plaque-induced gingivitis, a reversible condition, 
which, if not treated, can give rise to chronic 
periodontitis, which is considered irreversible.
[20] 
 
Among clinical features of chronic periodontitis, it is 
possible to find the following: redness or bleeding of 
gums, loss of insertion to the level of the bone, gingival 
margin recession, alveolar bone loss. In more advanced 
cases there is still increased dental mobility, furcation 
exposure and eventual dental loss.
[20] 
 
The prevalence of chronic periodontitis is higher in 
adults, being directly related to oral hygiene and plaque 
levels. Some local factors such as smoking, stress and 
systemic disease can predispose individuals to the 
development of this condition. These factors will be 
discussed later. 
 
The biofilm found in chronic periodontitis. contains a 
large variety of bacteria and subgingival calculus are 
usually found in this type of periodontitis.
[20]
 
 
Progression of chronic periodontitis is usually slow and 
moderate. This condition can be classified according 
with the extension of the affected region: localized when 
less than 30% of the sites are affected; or generalized 
when more than 30% of the sites are affected.
[20]
 
 
Moreover, the severity of the disease can be classified by 
measuring the loss of teeth insertion with the probe: mild 
if the loss is between 1-2 mm, moderate between 3-4 mm 
and severe when it is 5 mm.
[20]
 
 
2.2. Aggressive periodontitis 
Aggressive periodontitis includes a group of rare, rapidly 
progressing and frequently severe forms of periodontitis 
that generally affects young individuals (30 years of age 
or less), but it can also develop in older people.
[21]
 
 
Often, clinical manifestations start at an early age in 
opposition to chronic periodontitis that takes time to 
develop and occurs at older ages.
[21]
 This means that the 
etiological agents are able to cause clinical signs in a 
short period of time.  
 
In aggressive periodontitis a highly virulent microflora 
including mainly elevated proportions of Actinobacillus 
actinomycetemcomitans and Porphyromonas gingivalis 
is present usually together with a high level of 
susceptibility of the individual, leading to a rapid loss of 
tooth insertion.
[21] 
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In this type of periodontitis rapid loss of insertion and 
bone destruction are observed and the number of 
microbial deposits is incompatible with the destruction 
gravity and the extent of loss of surrounding tissue.
[21] 
 
Aggressive periodontitis can be classified into localized 
aggressive periodontitis or generalized aggressive 
periodontitis. The localized type is usually present in first 
molars and incisives and it does not affect more than two 
teeth other than those mentioned above.
[21]
 
 
3. Susceptibility Risk Factors  
There is still an enigma concerning the development of 
this disease because of the selective susceptibility 
between individuals. A great variety of risk factors are 
involved in its manifestation and progression, including 
environmental local factors such as the microbial 
composition of the plaque, where a diverse variety of 
microorganisms play an important role.
[22] 
 
Other environmental factors associated with lifestyle, 
such as smoking, nutrition (consumption of sugar, 
obesity), stress, depression, educational factors, race and 
inherited genetic variants.  can also be involved in the 
development of this condition.
[23-25] 
 
Some studies refer the influence of age and gender on 
periodontitis development. Aging is associated with the 
decline of health that increases the risk of chronic 
diseases like cancer, diabetes and atherosclerosis.
[26]
 This 
decline in health and physical activity also involves poor 
dental hygiene that can increase the risk of periodontitis 
development. This condition can also be associated with 
the other chronic conditions described before. 
 
Concerning gender, for some time, it has been 
recognized that males of all ages, ethnic groups and 
geographic locations have more periodontal disease than 
women. However, since no inheritance differences have 
been observed between the two sexes, the increased 
incidence of periodontitis in males can presumably be a 
consequence of different lifestyles between men and 
women, like smoking, alcohol consumption and different 
food diet habits that can influence the development of 
this disorder.
[27]
 
 
3.1. Environmental Risk Factors 
Smoking 
Smoking tobacco is a behavior with serious 
consequences for health including oral health. According 
with the International Classification of Diseases (tenth 
revision {ICD-10 F17}), when smoking becomes a habit 
and nicotine dependence is established, it is classified as 
a chronic medical disorder. Tobacco contains a large 
amount of toxins associated with cardiovascular diseases, 
various types of cancer and other chronic diseases, which 
makes it a potential risk factor for mortality as was found 
in the study made by de Center for disease control and 
prevention.
[28] 
 
More than 4,000 toxic substances have been found in 
cigarette smoke, such as oxidizing radicals, carbon 
monoxide, carcinogens (nitrosamine) and nicotine 
(which is addictive).
[29] 
 
Several studies have shown that periodontal support 
tissues can suffer adverse effects as a result of smoking, 
increasing 2 to 5 times the risk of periodontal disease.
[30]
 
Some studies found an association between tobacco 
consumption and the depth of periodontal pockets.
[31] 
 
The adverse effects found between tobacco consumption 
and periodontal disease can be categorized according 
with the effect of tabaco in microbiota and periodontal 
pathogens, in gingival blood flow, in the immunological 
area phagocytosis of polymorphonuclear neutrophils, in 
cytokines production (interleukin-1), in CD3, CD4 and 
CD8 and subsets of T cells and in healing of periodontal 
disease.
[32-34] 
 
It has been found that smokers present subgingival 
infections with specific periodontal pathogens such as P. 
gingivalis, T. denticola and T. forsythia, which increases 
both the risk of developing the disease and its 
progression.
[32-34] 
 
Moreover, smoking leads to peripheral vasoconstriction, 
decreasing gingival bleeding. This can also explain the 
existence of oxidation in the periodontal pocket and 
therefore the proliferation of a big number of anaerobic 
bacteria such as P. gingivalis and T. denticola.
[35-37] 
 
The use of tobacco modifies local and systemic 
inflammatory response, leading to a higher number of 
cytokines, achieving an exacerbated inflammatory 
response.
[32,38] 
 
Another evidence linking smoking with the 
etiopathogenesis of periodontal disease is that nicotine 
affects neutrophils function, since nicotine enhances 
neutrophils degranulation, increasing their sensitivity 
towards bacteria.
[39]
 
 
Obesity 
Obesity and overweight are a serious public health 
problem and have been increasing in recent years.
[40]
 
Several studies have found higher severity and 
prevalence of periodontal disease in individuals with 
overweight and obesity.
[41] 
 
These conditions have an adverse effect on the general 
state of health, being responsible for the development of 
insulin resistance and chronic inflammatory state. It is 
believed that the association between periodontal disease 
and obesity results from the chronic state of 
inflammation present in obesity that increases 
susceptibility for periodontal disease.
[42] 
 
It has been found differences between the oral 
microbiota of obese individuals and of nonobese.  A 
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significantly higher number of T. forsythia in the obese 
individuals has been found, and the increased presence of 
this bacteria can lead to increased susceptibility for 
initiation and progression of periodontal disease.
[43] 
 
Moreover, obese individuals developed more often 
several types of infections (post-operative and 
nosocomial infections) than normal weight people.
[42,44]
 
This can be explained by the participation of adipose 
tissue in inflammation and immunity.
[42,44]
 In obesity 
state, adipocytes are metabolically active and release a 
big variety of proinflammatory factors.
[45]
 In addition, in 
this state increased number of macrophages are present, 
that may also contribute to the release of inflammatory 
mediators.
[46] 
 
Work of Genco et al.
[47]
 showed that overweighed 
individuals presented a higher level of tumor necrosis 
factor. This study also found that obese subjects with 
insulin resistance presented a more severe periodontitis, 
suggesting that the release of this proinflammatory factor 
by adipose tissue can contribute to insulin resistance and 
consequently to periodontal disease.
[47]
 
 
Metabolic Syndrome 
The metabolic syndrome is a cluster of metabolic and 
physiological alterations including excess body fat 
around the waist and abdominal area, increased blood 
pressure, elevated plasma glucose and, in certain 
individuals, altered cholesterol levels. Consequently, this 
syndrome increases the risk of stroke, diabetes, heart 
disease and type 2 diabetes. 
 
Risks factors for metabolic syndrome include race, age, 
obesity, history of diabetes and diseases such as 
cardiovascular disease, hypertension and polycystic 
ovary syndrome.
[48] 
 
Several studies focused on looking for evidence of 
association between metabolic syndrome and periodontal 
disease. One of the first performed studies
[49]
 examined 
the relationship between five signs/symptoms of 
metabolic disease and periodontitis: high plasma levels 
of triglyceride and glucose levels, low level of high-
density lipoprotein, obesity and high blood pressure. 
These researchers found that patients with 4 of these 
signs/symptoms presented deepest pockets. Moreover, 
the signs with highest effect were altered high-density 
lipoprotein and fasting plasma glucose.
[49] 
 
The mechanism explaining the association between 
metabolic syndrome and periodontal disease, seems to be 
close to the mechanism of obesity since there is a chronic 
systemic inflammatory response resulting from the 
presence of some signs such as hyperglycemia, reduced 
high density lipoprotein and, as mentioned before, 
obesity. These patients show higher number of 
proinflammatory molecules causing an elevated systemic 
inflammatory response. Consequently, the destructive 
immunopathologic response of these individuals 
increases, resulting in a higher tissue destruction.
[50,51] 
 
However, there are still unanswered questions 
concerning which symptoms have the strongest 
association with periodontitis, but there is reasonable 
evidence to expect that obesity and diabetes will strongly 
affect the susceptibility or progression of periodontal 
disease.
[49] 
 
Moreover, the relationship between periodontal disease 
and diabetes applies in both directions.  It has been 
observed that diabetes increases the risk of periodontitis 
development and it has also been found that after 
periodontal treatment diabetic patients experience an 
improvement of plasma glycemic control.
[52]
 
 
Diabetes 
Diabetes mellitus belongs to a group of metabolic 
diseases that occur in several forms, being characterized 
by hyperglycaemia that can result from defects in insulin 
production, insulin action or both. Diabetes is associated 
with damage and consequent disfunction of several 
organs.
[53,54]
 Among symptoms developed by individuals 
with marked hyperglycaemia, are polyuria, polydipsia, 
weight loss, polyphagia and blurred vision. Patients with 
chronic hyperglycaemia may have higher susceptibility 
to infections. Other long-term complications include 
retinopathy with potential loss of vision, neuropathies 
with risk of feet ulcers and amputation and nephropathy 
leading to renal failure. 
 
Considerable evidence has been found for diabetes as a 
risk factor for development of periodontal diseases. It has 
been observed that diabetic individuals with periodontal 
disease, when submitted to periodontitis treatment have a 
consistent reduction in glycated hemoglobin. For this 
reason, it is considered the existence of a bidirectional 
relationship between diabetes and periodontitis since this 
interrelationship works in both directions.
[7] 
 
Persistence of hyperglycaemia leads to an exaggerated 
immuno-inflammatory response to pathogens of 
periodontal disease resulting in faster and severe 
destruction of periodontal tissue.
[55-57] 
 
Several studies have been published on the effects on 
glycaemic control after periodontal treatment. Some 
studies found an improvement in glycaemia control in 
patients with type 2 diabetes that were submitted to 
periodontitis treatment.
[57,58]
 However, no consensus was 
reached regarding treatment effects in type 1 
diabetes.
[57,58] 
 
It has also been found that inflammation and infection 
can lead to insulin resistance.
[45,59]
 This finding supports 
the effect on glycaemic control of periodontal infection 
treatment, due to the decrease in inflammation.
[45,59]
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Nutrients and Food Diet 
Many dietary nutrients can play an important role in the 
development of some inflammatory conditions like low 
levels of certain micronutrients, especially vitamin D or 
consumption of monosaccharides and disaccharides, 
since they may increase the risk of some inflammatory 
condition such as inflammatory bowel diseases, Crohn’s 
disease and ulcerative colitis.  
 
Several dietary regimes may modify disease symptoms, 
in part through their actions on the gut microbiota.
[60,61] 
 
Other studies have proven that diet can modify the risk 
of development of chronic diseases such as 
cardiovascular disease and cancer, but, so far, no specific 
linkage between diet and periodontal disease was 
established.
[62] 
 
Moreover, the role of dietary calcium in the development 
of this condition was studied and researchers found 
statistically significant association between low intake of 
dietary calcium and more severe level of periodontal 
diseases (specially in women).
[63] 
 
Some studies show that consumption of vitamin D and 
calcium can help in the treatment of periodontal disease, 
having beneficial effects on tooth retention.
[64] 
 
Singh-Dang et al.
[62]
 emphasized the importance of the 
interaction between diet and genotype of the individual. 
This interaction can have a higher connection with the 
development or severity of periodontitis and not just 
nutrients alone. So further studies should be made to 
have a clear answer for the association between dietary 
and periodontal disease.   
 
Stress and Depression 
Studies show evidence of psychological stress playing an 
important role in the development of major depression. 
Major depression is a severe widespread psychiatric 
disorder, life-threatening and highly prevalent, that is 
becoming one of the major causes of death worldwide.
[65]
 
It is the fifth among the leading causes of global disease 
in the ranking established by Mathers & Loncar.
[66] 
 
Chronic stress and depression have negative impacts in 
the inflammatory response of the host. It can increase the 
risk of diseases such as diabetes, atherosclerosis, 
cardiovascular disease and other systemic conditions. 
Consequently, it can modify the host defense and 
progression of periodontitis.
[67] 
 
Depression can also be associated to changes in health-
related behaviors. In this way, it might lead to poor oral 
hygiene, bad food diet, fewer dental visits and increased 
smoking, contributing to increased predisposition for 
periodontal disease.
[67] 
 
Moreover, other studies also showed that depression 
delayed the wound healing by adversely affecting the 
immune system.
[68] 
 
Three studies looked at the biological mechanism of 
stress in periodontal disease. One of these studies 
showed that cortisol levels were associated with severity 
and extent of the disease. Higher cortisol levels were 
indicative markers of stress and were associated with 
higher levels of periodontal disease.
[69]
 The second 
study
[70]
 demonstrated a positive relationship between 
depression, cortisol and β-endorphins and the 
development of periodontal disease and consequent tooth 
loss. 
 
In the third study, researchers observed that patients with 
salivary cortisol have an important association with 
attachment loss in periodontal pocket and tooth loss. This 
can be due to an altered immune response that facilitate 
increased colonization by pathogenic bacteria and 
breakdown of the periodontal attachment.
[71]
 
 
3.2. Genetic Risk Factors 
Periodontal disease is initiated mainly by microorganism 
in the subgingival biofilm, but other risk factors can play 
an important role in its development and progression. 
Nowadays, it is evident that genetic factors are also 
involved in the susceptibility for this disorder.  
 
Genetic factors regulate the innate immune system and 
certain polymorphisms may affect the effective response 
of the immune system and render it unable to 
successfully protect from pathogens assaults. In this way, 
genetics factor may have a stronger role in aggressive 
periodontitis than in chronic periodontitis.
[72]
 
 
Familiar aggregation and twin studies  
Many studies have observed that the prevalence of 
aggressive periodontitis is high among certain families, 
which show a prevalence of 40 to 50%.
[73-75] 
 
Study of Butler
[73]
 observed in a family with one brother 
and a sister having aggressive periodontitis (also called 
juvenile periodontitis), the same pattern of bone loss in 
the first molar and hard and shiny root surfaces with little 
or no calculus attached in the deep pockets.
[73]
 This last 
observation is very important since, as discussed above, 
one of the major etiological factors involved in initiation 
and progression of inflammation is the bacterial biofilm 
and, in this study, it is not presented, suggesting that 
genetic factors must be involved in susceptibility to 
aggressive periodontitis.
[76]
 This susceptibility points to 
familiar aggregation but may also reflect that families are 
exposed to similar environmental factors, such as diet, 
nutrition, oral hygiene, pollution and smoke (active and 
passive). Moreover, some pathogens can also cluster in 
families.
[77] 
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It has been proposed that aggressive periodontitis can be 
inherited as an autosomal recessive, autosomal dominant 
or X-linked trait but there are still no clear results.
[75] 
 
It has been shown that localized aggressive periodontitis 
is related to leukocytes disfunction in certain races and 
that this dysfunction can be genetically inherited.
[75] 
 
Concerning chronic periodontitis, few studies on family 
aggregation have been published, since this type of 
periodontitis is less common. Nevertheless, one of these 
studies
 [78]
 concluded that parents with poor periodontal 
health tend to have children with poor periodontal health. 
These researchers found that both genetic factors and 
environmental factors are shared in the family but were 
not able to distinguish between the environmental and 
genetic factors that predispose to the development of 
periodontal disease.
[78] 
 
Michalowics et al.
[77]
 studied dizygotic and monozygotic 
twins and concluded the existence of genetic factors in 
inheritance of periodontal disease. This study found that 
38 to 82% of the population variability for measures of 
depth of probe (periodontal pocket), insertion loss, 
gingivitis and dental plaque of periodontal disease can be 
attributed to genetic factors.
[77] 
 
Further studies found discordance between twins 
regarding the severity of attachment loss, suggesting that 
the role of genetics in the development of chronic 
periodontitis between twins may have been 
overestimated.
[75,79]
 
 
Polymorphisms 
Nowadays, researchers are showing a lot of interest in 
the role of genes and their variants (polymorphisms) in 
the development of periodontal disease, the response of 
the host and its progression. 
 
It has been demonstrated that genetic polymorphisms are 
determinant for the result of a disease, since they can 
cause changes in gene expression and synthesis of coded 
proteins or can cause changes the protein structure and 
lead to alterations in the innate and adaptive immune 
response. Hence, multiple genes and their 
polymorphisms may have a contribution to the 
susceptibility and severity of the disease.
[80]
 
 
Calprotectin 
Calprotectin is a proinflammatory mediator involved in 
the regulation of several cell processes like cell cycle 
progression and differentiation. It is known to participate 
in multiple regulatory functions in periodontitis and other 
inflammatory diseases such as cystic fibrosis. This 
molecule belongs to the calcium-binding protein family 
and is a heterodimer constituted by two subunits 
(S100A8 and S100A9). It is released by activated 
neutrophils and leukocytes.  
 
A study was conducted to investigate the relationship 
between aggressive periodontitis and the level of plasma 
calprotectin, and to determine the influence of S100A8 
gene polymorphisms and the level of calprotectin in 
patients with aggressive periodontitis.  It was found that 
individuals with aggressive periodontitis have a 
significant level of calprotectin in plasma.
[81,82]
 
Moreover, the percentage of allele rs3795391 of the 
S100A8 gene was significantly higher in patients with 
aggressive periodontitis than in controls, while the 
frequency of the rs3806232 polymorphism was lower in 
patients when compared with controls.
[81,82]
 These 
differences were observed in male patients. These 
findings suggest that these two single nucleotide 
polymorphisms of the S100A8 gene, might be associated 
with susceptibility to periodontal disease and gender can 
play a role in individual predisposition. 
 
It has been demonstrated in other studies that the 
combined effects of gender and polymorphism can 
interfere with the susceptibility to certain diseases like 
lung cancer and heart disease.
[83]
 
 
Other studies found a higher level of calprotectin in the 
crevicular fluid than found in plasma. This observation 
can indicate that abundant calprotectin present in 
periodontal tissue is the reason for the high level found 
in plasma.
[84,85]
 
 
Vitamin D  
Vitamin D is a steroid molecule that regulates the 
expression of many genes. It also plays an important role 
in bone metabolism and in the homeostasis of 
phosphorus. The best indicator of vitamin D levels in an 
individual is blood concentration of the calcifediol 
hormone.
[86] 
 
Liu et al. (2009) found that plasma calcifediol levels in 
patients with aggressive periodontitis were significantly 
higher than in healthy controls.
[87] 
 
Vitamin D has pleiotropic effects, and this explains the 
widespread presence of vitamin D receptors (VDRs) 
throughout the body.  VDR receptor is not only found in 
tissues involved in calcium homeostasis but also in a 
variety of cell lines involved primarily in immune 
regulation, including the mononuclear cells, dendritic 
cells, antigen-presenting cells, and activated B 
lymphocytes and CD4+ T cells. Therefore, it is thought 
that it can play an important role in inflammatory and 
autoimmune disease. Several reports link low vitamin D 
levels with various autoimmune diseases.
[88] 
 
Several studies have investigated the association between 
VDR polymorphisms and periodontitis in different 
populations. These studies observed that the frequency of 
the rs731236 allele, the less abundant allele in the 
population, was significantly higher in patients with 
periodontitis than in controls. These findings were seen 
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in Caucasian individuals from the UK, Chinese and 
Italians.
[89-91] 
 
However, Park et al. 
[92]
 did not observe association of 
that polymorphism with susceptibility to aggressive 
periodontitis in Korean individuals. On the other hand, 
these researchers found higher levels of another 
polymorphism (rs2228570) in patients with this 
condition.
[92] 
 
Another study found the association of the rs731236 
allele with chronic periodontitis but not with aggressive 
periodontitis in an Asiatic population, but this was not 
observed in white individuals.
[93]
 Moreover, the 
rs2228570 polymorphism was found to be a risk factor 
for aggressive periodontitis in the same population.
[93]
 
Other tested polymorphism did not show significative 
association with susceptibility to any type of 
periodontitis.
[93] 
 
Cytokines 
Interleukin-1 is a potent immunomodulator and 
proinflammatory cytokine. This cytokine has been 
associated with the pathogenesis of autoimmune and 
infectious diseases. It has also been suggested as a risk 
factor for aggressive periodontitis. 
 
Many studies have investigated the association of 
aggressive periodontitis and interleukin-1 polymorphism. 
Results were not consistent or did not have enough 
evidence of this association in Caucasian individuals.
[94]
 
However, significant association in other ethnic groups 
was observed. This was the case of the study of 
Guzeldemir et al.
[95]
 where IL-1 gene polymorphisms 
were associated with increased susceptibility to 
aggressive periodontitis in the Turkish population. 
 
Another cytokine possibly involved in susceptibility to 
periodontitis is interleukin-6. This cytokine also has 
proinflammatory and inflammatory functions. Some 
studies have been conducted to evaluate the association 
of IL6 gene polymorphism with periodontal disease.  
 
One of these studies observed that IL-6 -1363 
polymorphism was associated with aggressive 
periodontitis in patients from all ethnicities, while -1480 
and -6106 polymorphisms were present in Caucasian 
individuals with localized aggressive periodontitis.
[96] 
Moreover, a meta-analysis study performed by Shao et 
al.
 [97]
 concluded that the IL-6 -174 allele did not interfere 
with chronic periodontitis, however, was associated with 
increased risk of the aggressive form. On the other hand, 
the -572 polymorphism affected the pathogenesis of both 
types of periodontitis.
[97] 
 
Another work of Nibali et al.
[98]
 concluded that IL-6 
polymorphisms were moderately associated with 
susceptibility to periodontal disease. In Caucasians, -
1480 and -6106 polymorphisms slightly increased the 
risk of periodontitis and this association was stronger for 
localized aggressive periodontitis.
[98]
 These researchers 
believed that this association resulted from their 
influence on IL-6 tissue levels. 
 
Moreover, Nibali et al.
[99]
 were able to associate some 
IL-6 polymorphisms with the presence of certain 
bacterial species in subgingival biofilms of individuals 
with severe forms of periodontitis. The IL-6 -6106 
polymorphism was associated with the presence of A. 
actinomycetemcomitans and concomitant presence of A. 
actinomycetemcomitans and P. gingivalis, as well as the 
IL-6 -174 polymorphism.
[99]
 This data agrees with the 
hypothesis of periodontitis susceptibility being increased 
by a complex interaction between the microbiome and 
the host genome. 
 
Epigenetics 
Epigenetics refers to the interactions between 
environmental factors and genes that influence in their 
expression. These interactions are independent on DNA 
sequences and occur mainly by DNA methylation and 
changes in the chromatin structure.  
 
As referred by Ubeda & Wilkins
[100]
, epigenetic 
modifications can be established in different cell lines 
and can be responsible for different expressions in 
different tissue types.
[100] 
 
Usually, DNA methylation occurs in a region of DNA 
that contains cytosine followed by guanine nucleotides 
(CpG islands) in the linear sequence of bases along its 5' 
→ 3' direction.[101] 
 
It is known that methylation of a gene is associated with 
inactivation of its expression and that patterns of 
methylation can be inherited from the mother or acquired 
during life. Acquired methylation can be associated with 
systemic exposure such as smoking, that seems to affect 
the inflammatory state of the periodontal tissue in 
response to injury or infection.
[101] 
 
Work of Zhang et al.
[102]
 showed evidences of post-
translational methylation of genes, in periodontal 
disease. These researchers reported that chronically 
inflamed periodontal tissues exhibited an increased 
generalized methylation affecting levels of 
prostaglandins, as compared with non-inflamed 
periodontal tissues. This observation indicates that this 
effect can be significant for the chronicity of the 
periodontal disease.
[102] 
 
It has been suggested that the presence of bacteria can 
trigger changes in the epigenome of epithelial cells and 
subsequently in inflammatory cells, by inducing 
alterations in signalling pathways and gene expression. 
In fact, pathogens usually associated with periodontitis 
such as P. gingivalis and F. nucleatum can induce 
histone acetylation. Furthermore, activation of pathogen 
recognition receptors and Toll-like receptors (TLR) by 
these bacteria further contribute to histone modifications 
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in oral epithelial cells.
[103]
 Toll-like receptors have an 
important role on the activation of the innate immune 
response, since they are able to recognize pathogen 
molecules such as bacterial lipopolysaccharide. So, 
dysregulation of the expression of these receptors will 
probably affect host immune response towards 
periodontal pathogens and can lead to increased 
inflammation and hence periodontitis susceptibility. 
Work of Oliveira et al.
[104]
 did not see significative 
differences in the methylation pattern of the TLR4 and 
TLR2 genes between healthy individuals and 
periodontitis patients. However, study of Faria 
Amormino et al.
[105]
 observed a higher degree of 
methylation in the TLR2 gene in periodontitis patients 
when compared with controls, that was directly related 
with the number of inflammatory cells. These findings 
indicate that differences in these studies results probably 
result from the degree of inflammation of sample cells 
used. 
 
Another study showed that the presence of P. gingivalis 
in gingival epithelial cells induced DNA methylation.
[106]
 
Martins et al.
[103]
 observed that the pathogen besides 
inducing histone acetylation, also activated the 
transcription factor nuclear factor-kb (NFkB) in oral 
epithelial cells. This transcription factor is involved in 
activation of the innate immune system, osteoclast 
differentiation and induces matrix metalloproteinases and 
adhesion molecules.
[103]
 Moreover, it was seen that 
NFkB binding sites in the promoter region of the LTR2 
gene were methylated, probably affecting the binding of 
that transcription factor.
[104] 
 
Takai et al.
[107]
 observed that long-term treatment of 
periodontal fibroblast cells with P. gingivalis leads to 
hypermethylation of diverse genes involved in the 
formation of the extracellular matrix. It is believed that 
this hypermethylation reduces the production of matrix 
proteins such as cell surface receptors, affecting in this 
way adhesion of cells to the extracellular matrix and 
consequent loss of supporting tissue observed in 
periodontitis. 
 
Other studies observed a decreased level of methylation 
in promoter regions of genes coding for cytokines in 
gingival tissue from patients with aggressive 
periodontitis.
[108,109]
 This is in accordance with the fact 
that cytokines play an important role in the host immune 
response towards infecting bacteria. Schulz et al.
[109]
 
suggested that the increased gene expression resulting 
from their hypomethylation may be related to the loss of 
periodontal attachment in periodontal disease. 
 
Data even showed that these epigenetic changes can 
differ among different tissues from the same 
patient.
[110,111]
 
 
DISCUSSION AND CONCLUSION 
Previously it was believed that periodontal disease was 
only developed thanks to microbial factors and that all 
individuals were equally susceptible to its development. 
This believe changed gradually due to years of research 
that observed that some individuals do not suffer from 
this disease throughout their lives while others developed 
it and with different degrees of severity. These 
observations allowed to accept that the host immune 
response must play an important role in this condition.  
 
Nowadays, this disease is seen as a multifactorial 
disorder, in which many environmental and genetic 
factors contribute to the susceptibility and development 
of periodontal disease.  
 
This work allowed the identification of factors that affect 
the susceptibility and development of periodontitis. 
Among these factors is tobacco that can increase its 
incidence 2 to 5 times. Smoking affects oral microbiome, 
the gingival blood flow, and also leads to 
vasoconstriction, leading to oxidation in the periodontal 
pocket. All these changes exacerbate the immune 
response leading to higher release of cytokines and 
affecting neutrophils function. 
 
A similar mechanism is observed in cases of individuals 
with obesity or metabolic syndrome that increases their 
susceptibility to periodontitis due to a chronic 
inflammatory response. Obese individuals show the 
release of a variety of proinflammatory factors due to 
activation of adipocytes while in the metabolic syndrome 
this same release was found, but due to the 
hyperglycemic state, to low levels of high-density 
lipoprotein and to obesity. 
 
Food diet regimen can also interfere with periodontitis 
susceptibility being affected by low calcium 
consumption. Other factors that have been associated 
with periodontal disease are stress and depression. High 
levels of cortisol in saliva within the periodontal pockets 
of the patient with periodontitis have been found, being 
this hormone indicative of a stress condition. Depression 
interferes with mood and attitude of individuals and can 
lead to decreased health care and oral hygiene that can 
contribute to periodontitis. Depression may also affect 
the immune response of the organism, delaying bone 
healing. 
 
Concerning genetic factors, it has been found that 
polymorphisms of certain genes can increase periodontal 
disease susceptibility. This is the case of the S100A8 
gene coding for one subunit of calprotectin. Some 
polymorphisms of this gene are preferentially found in 
patients with aggressive periodontitis. Another example 
is the case of polymorphisms of the gene coding for 
vitamin D receptors. 
 
Many studies also point out the relationship between 
polymorphisms of genes coding for some interleukins 
and the susceptibility to periodontal disease, since these 
molecules are potent immunomodulators and 
proinflammatory cytokines. 
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Moreover, epigenetic factors such as DNA methylation 
and histone acetylation that alters chromatin structure are 
known to affect gene expression. Studies have found that 
chronically inflamed periodontal tissue had increased 
levels of methylation in genes leading to altered levels of 
prostaglandins that may favor the chronicity of this 
disease. Several studies indicate that such epigenetic 
changes influence production of signaling molecules and 
their molecular signaling pathways, affecting host 
immune response and influencing tissue degradation 
during periodontal disease. 
 
All these factors can affect the patient’s susceptibility to 
periodontal disease. So, the elimination of some of the 
environmental factors that can be modified, can help in 
the combat of periodontitis.  
 
Knowledge about the involved etiological factors can 
help to better understand this multifactorial disease, that 
should be treated as such, trying to reduce factors that 
interfere with the applied treatment. The dental doctor 
should suggest to patients several changes in lifestyle 
such as diet, exercise, stop smoking, stress reduction, 
helping in this way in prevention of periodontitis.  
 
A lot of progress in the genetic field is still needed, 
aiming that one day it will be possible to determine the 
susceptibility of each person to a certain disease such as 
periodontitis and hence help in preventing its 
development. 
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